Trial Profile
A Randomised, Open-label, Single-centre, Single- and Multiple-dose Interventional Study Investigating the Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Sep 2019
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary)
- Indications Anxiety disorders; Binge-eating disorder; Bipolar depression; Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Lundbeck A/S
- 24 Sep 2019 Results (n=186) of pooled analysis of this and other two studies (NCT01676571 and NCT01571453) assessing pharmacokinetic analysis in Chinese and non-Chinese healthy subjects, published in the Advances in Therapy.
- 18 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Mar 2015 New trial record